::: 큐라티스 :::

메뉴 바로가기: 주메뉴 바로가기; 컨텐츠 바로가기

SITE MAP

ABOUT US
- About us
- History
BUSINESS
R&D
PR
- Notice
- Press
- PR data
- Tuberculosis News
- Careers
IR
- 공시정보
- Careers

ABOUT US
- About us
- History
BUSINESS
R&D
PR
- Notice
- Press
- PR data
- Tuberculosis News
- Careers
IR
- 공시정보
- 공고

Quratis

Tel : +82 2 866 0604 Fax : +82 2 867 0125 Email : info@quratis.com

R&D

Vaccine (TB Prevention)

10-1624208
Vaccine composition for tuberculosis containing Rv0351 protein

Registration
10-1579861
Vaccine composition for tuberculosis containing Rv3131 protein

Registration
10-1568736
Vaccine composition for tuberculosis containing MTBK_24820

Registration
10-1672352
Vaccine composition for tuberculosis containing MTBK_20620

Registration
10-1705769
Vaccine composition for tuberculosis containing MTBK_20640

Registration
10-2019-0010431
Vaccine composition for preventing tuberculosis containing a glycosylated Ag85A protein and method for producing the vaccine composition

Prosecution

Cell Therapy Platform (Dendritic Cell)

10-1828044
Composition for treating and preventing of tuberculosis comprising dendritic cell and antibiotic agent

Registration
10-1892598
Composition for boosting of tuberculosis vaccine comprising dendritic cell

Registration
10-2003958
Pharmaceutical composition for preventing or treating hypersensitivity immune disease and the method for preparing thereof

Registration
10-1749165
Maturation compositions of dendritic cell containing the Rv2299c protein or Rv2299c fused ESAT-6 protein

Registration
10-1946572
Tolerorgenic plasmacytoid dendritic cells and the method for preparing thereof

Registration
10-1893886
Pharmaceutical composition for preventing or treating autoimmune disease and the method for preparing thereof

Registration

Peptide Nucleic Acid (PNA)

10-1501099
Novel PNA and antibacterial composition comprising the same

Registration
10-1535874
Novel PNA and antibacterial composition comprising the same

Registration

STING Agonist

10-1982710
Adjuvant and vaccine composition comprising STING agonist

Registration
10-2122955
Adjuvant and vaccine composition comprising STING agonist

Registration

TB Detection

10-1802417
A multiplex PCR primer set, a composition and a kit comprising the same for diagnosing Mycobacterium tuberculosis and non-tuberculous mycobacteria

Registration

Biomarker

10-2019-0151914
Biomarker for diagnosing infectious disease by nontuberculous mycobacteria

Prosecution
10-2019-0151915
Biomarker for predicting the treatment response of inflammation by nontuberculous mycobacteria

Prosecution
10-2019-0151924
Biomarker for predicting spontaneous bacteriuim negative after the infection by nontuberculous mycobacteria

Prosecution
10-2019-0151926
Biomarker for predicting the prolonged positive result after the infection by nontuberculous mycobacteria

Prosecution
10-2019-0151931
Biomarker for differentiating infectious disease by nontuberculous mycobacteria

Prosecution

Host directed treatment

10-2019-0141597
Composition for host directed treatment

Prosecution

Company: Quratis

TEL: +82 2-866-060

IR: +82 070-4141-5942

Partners

SITE MAP

ABOUT US

BUSINESS

R&D

PR

IR

ABOUT US

BUSINESS

R&D

PR

IR

R&D

Patent

Vaccine (TB Prevention)

Vaccine composition for tuberculosis containing Rv0351 protein

Vaccine composition for tuberculosis containing Rv3131 protein

Vaccine composition for tuberculosis containing MTBK_24820

Vaccine composition for tuberculosis containing MTBK_20620

Vaccine composition for tuberculosis containing MTBK_20640

Vaccine composition for preventing tuberculosis containing a glycosylated Ag85A protein and method for producing the vaccine composition

Cell Therapy Platform (Dendritic Cell)

Composition for treating and preventing of tuberculosis comprising dendritic cell and antibiotic agent

Composition for boosting of tuberculosis vaccine comprising dendritic cell

Pharmaceutical composition for preventing or treating hypersensitivity immune disease and the method for preparing thereof

Maturation compositions of dendritic cell containing the Rv2299c protein or Rv2299c fused ESAT-6 protein

Tolerorgenic plasmacytoid dendritic cells and the method for preparing thereof

Pharmaceutical composition for preventing or treating autoimmune disease and the method for preparing thereof

Peptide Nucleic Acid (PNA)

Novel PNA and antibacterial composition comprising the same

Novel PNA and antibacterial composition comprising the same

STING Agonist

Adjuvant and vaccine composition comprising STING agonist

Adjuvant and vaccine composition comprising STING agonist

TB Detection

A multiplex PCR primer set, a composition and a kit comprising the same for diagnosing Mycobacterium tuberculosis and non-tuberculous mycobacteria

Biomarker

Biomarker for diagnosing infectious disease by nontuberculous mycobacteria

Biomarker for predicting the treatment response of inflammation by nontuberculous mycobacteria

Biomarker for predicting spontaneous bacteriuim negative after the infection by nontuberculous mycobacteria

Biomarker for predicting the prolonged positive result after the infection by nontuberculous mycobacteria

Biomarker for differentiating infectious disease by nontuberculous mycobacteria

Host directed treatment

Composition for host directed treatment